Volume 7, Issue 1 (2021)
Pharm Biomed Res 2021, 7(1): 63-66 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ghanbarzamani A H, Salehifar E, Kazemian K. A Case of Erythema Multiforme Caused by Sildenafil Plus Tramadol. Pharm Biomed Res 2021; 7 (1) :63-66
URL: http://pbr.mazums.ac.ir/article-1-361-en.html
URL: http://pbr.mazums.ac.ir/article-1-361-en.html
1- Pharmaceutical Research Center, Department of Clinical pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
2- Department of Clinical Pharmacy, Sina Hospital, Tehran University of Medicine, Tehran, Iran.
2- Department of Clinical Pharmacy, Sina Hospital, Tehran University of Medicine, Tehran, Iran.
Abstract: (2218 Views)
In this report, we present a 29-year-old man who experienced EM five days after using sildenafil and tramadol. Based on clinical examination and history, the diagnosis of EM was made confirmed via skin biopsy, which found intra-epidermal bulla filled by fibrinous exudate, some mononuclear cells, and a few eosinophils. The spongiotic epidermis showed lichenoid interface dermatitis, eosinophilic spongiosis, and necrolysis, consistent with EM diagnosis. Fluocinolone, 0.025% ointment, was prescribed for the patient, and the lesions healed after two weeks of treatment.
Type of Study: case report |
Subject:
Drug Clinical Investigation
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
